Arkolith/Insider Trading/NBP/Form 4

Xu Cong Claire

SVP, Clinical DevelopmentNovaBridge Biosciences (NBP) · full profile →Form 4 · filed Jun 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Sell(S)3K$3.94$14K290K
May 30, 2026Option exercise(M)9K——294K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 30, 2026Option exercise(M)4K—$033K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002114309-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML